Transverse Myelitis
📧 Sign up to get email alerts when something new happens for Transverse Myelitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Home Based Tele-exercise for People With Chronic Neurological Impairments [NA]
A clinical trial (NCT04564495) evaluating home-based tele-exercise for people with chronic neurological impairments is currently active but …
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis [Phase 1, Phase 2]
A clinical trial investigating the safety of transplanting human glial restricted progenitor cells in subjects with transverse myelitis is i…
-
CLINICAL_TRIALS trial_result · 2020-12-28Clinical Trial Update: A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease) [Phase 4]
Pilot Phase 4 trial investigating mitoxantrone for recurrent neuromyelitis optica (Devic's disease) has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Clinical Trial of a Serious Game for Individuals With SCI/D [NA]
The clinical trial evaluating a serious game for individuals with spinal cord injury and related conditions has completed; the update notes …
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Central Pain Study for ABX-1431 [Phase 1]
Phase 1 central pain study of ABX-1431 conducted by Abide Therapeutics has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch) [Phase 2]
A Phase 2 clinical trial evaluating sustained-release dalfampridine for transverse myelitis and related conditions has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis [Phase 4]
Long-term Phase 4 study investigating Avonex therapy after a first attack in multiple sclerosis patients; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis [Phase 3]
A Phase 3 multicenter randomized trial comparing intravenous immunoglobulin to standard therapy for transverse myelitis has been terminated.